The Cellular Prion Protein and the Hallmarks of Cancer - Sorbonne Université
Article Dans Une Revue Cancers Année : 2021

The Cellular Prion Protein and the Hallmarks of Cancer

Sophie Mouillet-Richard
  • Fonction : Auteur
  • PersonId : 969762
Alexandre Ghazi
Pierre Laurent-Puig
  • Fonction : Auteur
  • PersonId : 946934

Résumé

Beyond its causal involvement in a group of neurodegenerative diseases known as Transmissible Spongiform Encephalopathies, the cellular prion protein PrPC is now taking centre stage as an important contributor to cancer progression in various types of solid tumours. The prion cancer research field has progressively expanded in the last few years and has yielded consistent evidence for an involvement of PrPC in cancer cell proliferation, migration and invasion, therapeutic resistance and cancer stem cell properties. Most recent data have uncovered new facets of the biology of PrPC in cancer, ranging from its control on enzymes involved in immune tolerance to its radio-protective activity, by way of promoting angiogenesis. In the present review, we aim to summarise the body of literature dedicated to the study of PrPC in relation to cancer from the perspective of the hallmarks of cancer, the reference framework defined by Hanahan and Weinberg.

Domaines

Cancer
Fichier principal
Vignette du fichier
cancers-13-05032-v2.pdf (2.2 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03379898 , version 1 (15-10-2021)

Identifiants

Citer

Sophie Mouillet-Richard, Alexandre Ghazi, Pierre Laurent-Puig. The Cellular Prion Protein and the Hallmarks of Cancer. Cancers, 2021, 13 (19), pp.5032. ⟨10.3390/cancers13195032⟩. ⟨hal-03379898⟩
58 Consultations
99 Téléchargements

Altmetric

Partager

More